US Stocks
/
Black Diamond Therapeutics, Inc. Share Price

Black Diamond Therapeutics, Inc. Share Price

NASDAQ: BDTX | Micro Cap
$1.81
-$0.02 (-1.36%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Black Diamond Therapeutics, Inc. Stock Performance

Open
$1.81
Prev. Close
$1.83
Circuit Range
N/A
Day Range
$1.77 - $1.81
Year Range
$1.60 - $4.94
Volume
25,209
Average Traded
$1.79

Black Diamond Therapeutics, Inc. Share Price Today

As of 9 October 2026, Black Diamond Therapeutics, Inc.'s share price is $1.81. The stock opened at $1.81, compared to its previous close of $1.83. During today's trading session, Black Diamond Therapeutics, Inc.'s share price traded between $1.77 and $1.81, with an average price of $1.79. Over the past 52 weeks, the stock has recorded a high of $4.94 and a low of $1.60. In terms of performance, Black Diamond Therapeutics, Inc.'s share price has declined by 31.95% over the last six months and is down 53.47% on a year-on-year basis.

Black Diamond Therapeutics, Inc. Share Price Chart

$1.77$1.81
L
Show Current Price
H

Black Diamond Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$102.93M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.74
Revenue (TTM)
$70.00B
Return On Equity (TTM)
-44.29%
Profit Margin
31.96%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-16.59%

Black Diamond Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$8.50-$15.12-$9.04-$9.91
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-77.88%40.21%-9.62%

Black Diamond Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$70.00
Net Profit-$91.17-$82.44-$69.68$22.37
Net Profit MarginN/AN/AN/A31.96%
Income ChangeN/A9.58%15.48%132.10%

About Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.

Black Diamond Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.87
$1.80
-3.99%
Sep 2026
$2.09
$1.88
-17.18%
Aug 2026
$1.68
$2.27
+34.72%
Jul 2026
$1.85
$1.69
-8.67%
Jun 2026
$2.21
$1.84
-17.63%
May 2026
$2.63
$2.24
-15.79%
Apr 2026
$2.24
$2.66
+24.88%
Mar 2026
$2.34
$2.13
-13.59%
Feb 2026
$2.47
$2.46
-0.60%
Jan 2026
$2.46
$2.48
+1.64%
Dec 2025
$3.76
$2.44
-36.13%
Nov 2025
$3.95
$3.82
-1.80%

BDTX Share Price FAQs

What is Black Diamond Therapeutics, Inc. share price today?

chevron-up
Black Diamond Therapeutics, Inc. share price today is $1.81 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Black Diamond Therapeutics, Inc. stock?

chevron-up
The 52 week high of Black Diamond Therapeutics, Inc. stock is $4.94, while the 52 week low is $1.60 as of 9 Oct '26.

What is BDTX's market capitalisation today?

chevron-up
BDTX market capitalisation is $102.93M as of October 9, 2026, at 4:45 pm IST.

What is BDTX's net income for the last quarter?

chevron-up
BDTX's net income for the last quarter is -9.91B USD.

What is the 5 year returns of BDTX?

chevron-up
The 5 year returns of BDTX is -76.39% as on 9 Oct '26.

What is the high & low stock price of BDTX today?

chevron-up
BDTX stock price hit a high of $1.81 and low of $1.77 as of 9 Oct '26.

Can I buy BDTX shares in India?

chevron-up
Yes. You can buy BDTX in India by opening an international trading account.